Back
InnoCare Pharma Ltd. 10K Form
Sell
21
INCPF
InnoCare Pharma Ltd.
Last Price:
$1.55
Seasonality Move:
0%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INCPF News And Ratings
See the #1 stock for the next 7 days that we like better than INCPF
INCPF Financial Statistics
Sales & Book Value
| Annual Sales: | $328.1M |
|---|---|
| Cash Flow: | $25.3M |
| Price / Cash Flow: | 144.22 |
| Annual Sales: | $0.63 |
| Price / Book: | 2.47 |
Profitability
| EPS (TTM): | 0.05150 |
|---|---|
| Net Income (TTM): | $91M |
| Gross Margin: | $287.4M |
| Return on Equity: | 9.4% |
| Return on Assets: | 6.71% |
InnoCare Pharma Ltd. Earnings Forecast
Key InnoCare Pharma Ltd. Financial Ratios
-
The Gross Profit Margin over the past 9 years for INCPF is 87.59%.
-
The Selling, General & Administrative Expenses for INCPF have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 36.96% of Revenue.
-
The Interest Expense is 8.55% of Operating Income.
-
The Net Earning history of INCPF is 27.31% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 5 years.
InnoCare Pharma Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | INCPF |
| Website: | innocarepharma.com |
Debt
| Debt-to-Equity Ratio: | 0.21 |
|---|---|
| Current Ratio: | 5.83 |
| Quick Ratio: | 5.67 |
Price-to-Earnings
| Trailing P/E Ratio: | 30.57 |
|---|---|
| Forward P/E Ratio: | 0 |
INCPF Technical Analysis vs Fundamental Analysis
Sell
21
InnoCare Pharma Ltd. (INCPF)
is a Sell
Is InnoCare Pharma Ltd. a Buy or a Sell?
-
InnoCare Pharma Ltd. stock is rated a SellThe current InnoCare Pharma Ltd. [INCPF] share price is $1.55. The Score for INCPF is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.